Compare Intuitive Surgical, Inc. (ISRG) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Nomura Holdings Inc — how do they compare? Intuitive Surgical, Inc. trades at $351.2 (market cap $125.08B), while Nomura Holdings Inc trades at $9.4 (market cap $27.46B). The key difference: Intuitive Surgical, Inc. is far larger — about 4.6× Nomura Holdings Inc's market cap, and Nomura Holdings Inc pays a 3.45% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| ISRG | NMR | |
|---|---|---|
Market Cap | $125.08B | $27.46B |
Sector | Health | Financials |
52-Week High | $592.85 | $10.04 |
52-Week Low | $345.42 | $6.39 |
Enterprise Value | $116.45B | — |
Dividend Yield | — | 3.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
